Contact Us
Intravenous Therapy Solutions Global Market Report 2025
Global Intravenous Therapy Solutions Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Intravenous Therapy Solutions Global Market Report 2025

By Product Type (Crystalloids, Colloids, Blood Products, Other Product Types), By Application (Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Intravenous Therapy Solutions Market Overview

• Intravenous Therapy Solutions market size has reached to $11.95 billion in 2024

• Expected to grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%

• Growth Driver: Growing Demand For Minimally Invasive Therapies Driving The Market Growth Due To Increasing Preference For Faster Recovery And Reduced Postoperative Pain

• Market Trend: Standardized IV Solutions Gaining Momentum In Clinical Practice

North America was the largest region in 2024.

What Is Covered Under Intravenous Therapy Solutions Market?

Intravenous therapy solutions refer to sterile liquid formulations that are administered directly into a patient’s vein to deliver fluids, medications, nutrients, or electrolytes. These solutions treat dehydration, electrolyte imbalances, infections, and provide essential nutrients when oral intake is not possible. They are commonly composed of water, salts, sugars, or medicinal compounds and are tailored based on patient needs and medical conditions.

The main product types of intravenous therapy solutions are crystalloids, colloids, blood products, and others. Crystalloids are intravenous fluids composed of water and electrolytes, used to quickly restore hydration and fluid balance in medical emergencies. These solutions are used for various applications such as fluid and electrolyte imbalance, nutritional support, medication administration, blood transfusion, and others. They are provided across various end users, including hospitals, clinics, ambulatory surgical centers, home care settings, and others.

Intravenous Therapy Solutions Market Size and growth rate 2025 to 2029: Graph

What Is The Intravenous Therapy Solutions Market Size 2025 And Growth Rate?

The intravenous therapy solutions market size has grown rapidly in recent years. It will grow from $11.95 billion in 2024 to $13.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing hospital admissions, rise in surgical procedures, growing incidence of dehydration, higher prevalence of chronic diseases, and improving access to healthcare infrastructure

What Is The Intravenous Therapy Solutions Market Growth Forecast?

The intravenous therapy solutions market size is expected to see rapid growth in the next few years. It will grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the rising elderly population, the expansion of home healthcare services, the increasing demand for rapid rehydration treatments, the growing prevalence of gastrointestinal disorders, and the increasing use of single-use IV components. Major trends in the forecast period include advancements in IV drug delivery systems, a shift towards home-based IV therapy, integration of smart infusion pumps, growth in biologic and specialty drug infusions, and rising preference for customized IV nutrition therapy.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Intravenous Therapy Solutions Market Segmented?

1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types

2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users

Subsegments:

1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline

2) By Colloids: albumin, Dextran, Hydroxyethyl Starch (HES), gelatin

3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate

4) By Other Product: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives

What Is Driving The Intravenous Therapy Solutions Market? Growing Demand For Minimally Invasive Therapies Driving The Market Growth Due To Increasing Preference For Faster Recovery And Reduced Postoperative Pain

The growing demand for minimally invasive therapies is expected to drive the growth of the intravenous therapy solutions market in the future. Minimally invasive therapies refer to medical treatments that involve minimal incisions or insertion into the body, often resulting in quicker recovery and reduced complications. The growing demand for minimally invasive therapies is due to their ability to reduce postoperative pain, which leads to faster patient recovery and improved overall comfort during the healing process. Intravenous therapy solutions support minimally invasive therapies by enabling the efficient delivery of essential fluids, medications, and nutrients directly into the bloodstream, ensuring optimal patient care and faster recovery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing surgical procedures by 2%. Therefore, the growing demand for minimally invasive therapies is driving the growth of the intravenous (IV) therapy solutions industry.

Who Are The Major Players In The Global Intravenous Therapy Solutions Market?

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited

What Are The Key Trends Of The Global Intravenous Therapy Solutions Market? Standardized IV Solutions Gaining Momentum In Clinical Practice

Major companies operating in the intravenous therapy solutions market are focusing on developing innovative solutions such as ready-to-use drug infusion to enhance treatment efficiency and reduce preparation time in clinical settings. Ready-to-use drug infusion refers to pre-mixed, pre-labeled intravenous (IV) medications that are prepared in standardized doses and packaging, eliminating the need for on-site compounding or dilution. For instance, in May 2024, B. Braun Medical Inc., a US-based manufacturing company, launched Levetiracetam in Sodium Chloride Injection, a ready-to-use intravenous anticonvulsant solution. This product is designed for the treatment of seizures and is available in standardized concentrations and volumes, eliminating the need for dilution or compounding at the point of care. The Levetiracetam IV formulation is pre-mixed in a flexible container, ensuring accuracy in dosing, reducing the risk of contamination, and enhancing convenience for healthcare professionals in emergency and inpatient settings.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Intravenous Therapy Solutions Market? Organon & Co. Acquired Tofidence Rights From Biogen To Expand U.S. Biosimilars Immunology Portfolio

In April 2025, Organon & Co., a US-based healthcare company, acquired the regulatory and commercial rights to Tofidence from Biogen Inc. With this acquisition, Organon & Co. aims to strengthen and expand its US biosimilars immunology portfolio by adding Tofidence to support treatment for multiple arthritis indications and COVID-19, while leveraging its commercial expertise and market access capabilities to drive long-term growth in the immunology segment. Biogen Inc. is a US-based biotechnology company that specializes in providing intravenous therapy solutions such as Tofidence.

What Is The Regional Outlook For The Global Intravenous Therapy Solutions Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Intravenous Therapy Solutions Industry?

The intravenous therapy solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including the intravenous therapy solutions industry global market size, regional shares, competitors with the market share, detailed market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous therapy solutions industry. These intravenous therapy solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abdul Wasay

Intravenous Therapy Solutions Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $13.17 billion
Revenue Forecast In 2034 $19.33 billion
Growth Rate CAGR of 10.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product Type, Application, End-User, Crystalloids, Colloids, Blood Products, Other Product
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Intravenous Therapy Solutions Market Characteristics

3. Intravenous Therapy Solutions Market Trends And Strategies

4. Intravenous Therapy Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intravenous Therapy Solutions Growth Analysis And Strategic Analysis Framework

5.1. Global Intravenous Therapy Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Intravenous Therapy Solutions Market Growth Rate Analysis

5.4. Global Intravenous Therapy Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Intravenous Therapy Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Intravenous Therapy Solutions Total Addressable Market (TAM)

6. Intravenous Therapy Solutions Market Segmentation

6.1. Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Crystalloids

Colloids

Blood Products

Other Product Types

6.2. Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fluid And Electrolyte Imbalance

Nutritional Support

Medication Administration

Blood Transfusion

Other Applications

6.3. Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Ambulatory Surgical Centers

Home Care Settings

Other End-Users

6.4. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Normal Saline (0.9% Sodium Chloride)

Half Normal Saline (0.45% Sodium Chloride)

Lactated Ringer’s Solution

Dextrose Solutions

Hypertonic Saline

6.5. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Albumin

Dextran

Hydroxyethyl Starch (HES)

Gelatin

6.6. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Packed Red Blood Cells (PRBCs)

Platelets

Fresh Frozen Plasma (FFP)

Cryoprecipitate

6.7. Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous Immunoglobulins (IVIG)

Parenteral Nutrition Solutions

Specialty Intravenous Drugs And Additives

7. Intravenous Therapy Solutions Market Regional And Country Analysis

7.1. Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous Therapy Solutions Market

8.1. Asia-Pacific Intravenous Therapy Solutions Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous Therapy Solutions Market

9.1. China Intravenous Therapy Solutions Market Overview

9.2. China Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous Therapy Solutions Market

10.1. India Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous Therapy Solutions Market

11.1. Japan Intravenous Therapy Solutions Market Overview

11.2. Japan Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous Therapy Solutions Market

12.1. Australia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous Therapy Solutions Market

13.1. Indonesia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous Therapy Solutions Market

14.1. South Korea Intravenous Therapy Solutions Market Overview

14.2. South Korea Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous Therapy Solutions Market

15.1. Western Europe Intravenous Therapy Solutions Market Overview

15.2. Western Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous Therapy Solutions Market

16.1. UK Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous Therapy Solutions Market

17.1. Germany Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous Therapy Solutions Market

18.1. France Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous Therapy Solutions Market

19.1. Italy Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous Therapy Solutions Market

20.1. Spain Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous Therapy Solutions Market

21.1. Eastern Europe Intravenous Therapy Solutions Market Overview

21.2. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous Therapy Solutions Market

22.1. Russia Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous Therapy Solutions Market

23.1. North America Intravenous Therapy Solutions Market Overview

23.2. North America Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous Therapy Solutions Market

24.1. USA Intravenous Therapy Solutions Market Overview

24.2. USA Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous Therapy Solutions Market

25.1. Canada Intravenous Therapy Solutions Market Overview

25.2. Canada Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous Therapy Solutions Market

26.1. South America Intravenous Therapy Solutions Market Overview

26.2. South America Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous Therapy Solutions Market

27.1. Brazil Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous Therapy Solutions Market

28.1. Middle East Intravenous Therapy Solutions Market Overview

28.2. Middle East Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous Therapy Solutions Market

29.1. Africa Intravenous Therapy Solutions Market Overview

29.2. Africa Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous Therapy Solutions Market Competitive Landscape And Company Profiles

30.1. Intravenous Therapy Solutions Market Competitive Landscape

30.2. Intravenous Therapy Solutions Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous Therapy Solutions Market Other Major And Innovative Companies

31.1. Grifols S.A.

31.2. Terumo Corporation

31.3. Dr. Reddy’s Laboratories Limited

31.4. Sichuan Kelun Pharmaceutical Co. Ltd.

31.5. Teleflex Incorporated

31.6. Hikma Pharmaceuticals PLC

31.7. ICU Medical Inc.

31.8. Biocon Limited

31.9. B. Braun Melsungen Aktiengesellschaft

31.10. JW Life Science Corporation

31.11. AdvaCare Pharma USA

31.12. Soxa Formulations & Research Pvt. Ltd.

31.13. Vifor Pharma Management Ltd.

31.14. Aetos Pharma Private Limited

31.15. LXIR Medilabs Private Limited

32. Global Intravenous Therapy Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous Therapy Solutions Market

34. Recent Developments In The Intravenous Therapy Solutions Market

35. Intravenous Therapy Solutions Market High Potential Countries, Segments and Strategies

35.1 Intravenous Therapy Solutions Market In 2029 - Countries Offering Most New Opportunities

35.2 Intravenous Therapy Solutions Market In 2029 - Segments Offering Most New Opportunities

35.3 Intravenous Therapy Solutions Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: Otsuka Pharmaceutical Co. Ltd. Financial Performance
  • Table 81: Baxter International Inc. Financial Performance
  • Table 82: Fresenius Kabi AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Crystalloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Colloids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Blood Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Intravenous Therapy Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Intravenous Therapy Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Intravenous Therapy Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Intravenous Therapy Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Intravenous Therapy Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Intravenous Therapy Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: Otsuka Pharmaceutical Co. Ltd. Financial Performance
  • Figure 81: Baxter International Inc. Financial Performance
  • Figure 82: Fresenius Kabi AG Financial Performance

Frequently Asked Questions

Intravenous therapy solutions refer to sterile liquid formulations that are administered directly into a patient’s vein to deliver fluids, medications, nutrients, or electrolytes. These solutions treat dehydration, electrolyte imbalances, infections, and provide essential nutrients when oral intake is not possible. They are commonly composed of water, salts, sugars, or medicinal compounds and are tailored based on patient needs and medical conditions. For further insights on the Intravenous Therapy Solutions market, request a sample here

The Intravenous Therapy Solutions market major growth driver - Growing Demand For Minimally Invasive Therapies Driving The Market Growth Due To Increasing Preference For Faster Recovery And Reduced Postoperative Pain. For further insights on the Intravenous Therapy Solutions market, request a sample here

The Intravenous Therapy Solutions market size has grown strongly in recent years. The intravenous therapy solutions market size has grown rapidly in recent years. It will grow from $11.95 billion in 2024 to $13.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing hospital admissions, rise in surgical procedures, growing incidence of dehydration, higher prevalence of chronic diseases, and improving access to healthcare infrastructure The intravenous therapy solutions market size is expected to see rapid growth in the next few years. It will grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the rising elderly population, the expansion of home healthcare services, the increasing demand for rapid rehydration treatments, the growing prevalence of gastrointestinal disorders, and the increasing use of single-use IV components. Major trends in the forecast period include advancements in IV drug delivery systems, a shift towards home-based IV therapy, integration of smart infusion pumps, growth in biologic and specialty drug infusions, and rising preference for customized IV nutrition therapy. For further insights on the Intravenous Therapy Solutions market, request a sample here

The intravenous therapy solutions market covered in this report is segmented –
1) By Product Type: Crystalloids, Colloids, Blood Products, Other Product Types
2) By Application: Fluid And Electrolyte Imbalance, Nutritional Support, Medication Administration, Blood Transfusion, Other Applications
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Other End-Users Subsegments:
1) By Crystalloids: Normal Saline (0.9% Sodium Chloride), Half Normal Saline (0.45% Sodium Chloride), Lactated Ringer’s Solution, Dextrose Solutions, Hypertonic Saline
2) By Colloids: Albumin, Dextran, Hydroxyethyl Starch (HES), Gelatin
3) By Blood Products: Packed Red Blood Cells (PRBCs), Platelets, Fresh Frozen Plasma (FFP), Cryoprecipitate
4) By Other Product: Intravenous Immunoglobulins (IVIG), Parenteral Nutrition Solutions, Specialty Intravenous Drugs And Additives For further insights on the Intravenous Therapy Solutions market,
request a sample here

North America was the largest region in the intravenous therapy solutions market in 2024. The regions covered in the intravenous therapy solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Intravenous Therapy Solutions market, request a sample here.

Major companies operating in the intravenous therapy solutions market are Pfizer Inc., Johnson & Johnson, Otsuka Pharmaceutical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Terumo Corporation, Dr. Reddy’s Laboratories Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Teleflex Incorporated, Hikma Pharmaceuticals PLC, ICU Medical Inc., Biocon Limited, B. Braun Melsungen Aktiengesellschaft, JW Life Science Corporation, AdvaCare Pharma USA, Soxa Formulations & Research Pvt. Ltd., Vifor Pharma Management Ltd., Aetos Pharma Private Limited, LXIR Medilabs Private Limited . For further insights on the Intravenous Therapy Solutions market, request a sample here.

Major trends in the Intravenous Therapy Solutions market include Standardized IV Solutions Gaining Momentum In Clinical Practice. For further insights on the Intravenous Therapy Solutions market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon